INS and obstructive sleep apnea syndrome: Diabetes-related weight gain, particularly associated with specific diabetes treatments such as sulfonylureas, thiazolidinediones, or insulin, can exacerbate OSA by increasing upper airway tissue mass and reducing airway diameter.